id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0128-0004,FDA,FDA-2008-D-0128,Guidance for Industry on Drug-Induced Liver Injury: Premarketing Clinical Evaluation; Availability,Notice,Notice of Availability,2009-07-30T04:00:00Z,2009,7,2009-07-30T04:00:00Z,,2016-01-06T18:52:41Z,E9-18135,0,0,09000064809fe4c8
FDA-2008-D-0128-0005,FDA,FDA-2008-D-0128,Drug-Induced Liver Injury: Premarketing Clinical Evaluation; Guidance for Industry,Other,Guidance,2009-07-29T04:00:00Z,2009,7,2009-07-29T04:00:00Z,,2024-11-12T04:35:42Z,,1,0,09000064809fe510